Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.52 |
| ▸ | G6PD | P11413 | 1/20 | 0.52 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL471119 | 1.00 | HPGD (0.64) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL2620355 | 1.00 | HPGD (0.64) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL44533 | 0.91 | — | — | |
| SCHEMBL13573418 | 0.89 | HPGD (0.52) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| Hydrochloric Acid SCHEMBL2866389 | 0.88 | MAPT (0.50) | HPGDMEN1KMT2ARAPGEF4MAPT | |
| SCHEMBL108881 | 0.88 | HPGD (0.78) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL50079 | 0.88 | HPGD (0.78) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL7338618 | 0.88 | TSHR (0.56) | HPGDGAAL3MBTL1MAPTTSHR | |
| SCHEMBL9516537 | 0.88 | HPGD (0.78) | HPGDGAAMEN1KMT2AL3MBTL1 | |
| SCHEMBL19248249 | 0.87 | HPGD (0.50) | HPGDGAAMEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006490-B2 | Method for direct functionalization of polyaniline and other molecules having diiminoquinoid ring via C-C bond formation | Han, Chien-Chung (TW) | 2015-04-14 | — | — | US | disclosed |
| US-20120130114-A1 | METHOD FOR DIRECT FUNCTIONALIZATION OF POLYANILINE AND OTHER MOLECULES HAVING DIIMINOQUINOID RING VIA C-C BOND FORMATION, AND PRODUCT YIELDED THEREWITH | Han, Chien-Chung (TW) | 2012-05-24 | — | — | US | disclosed |
| US-7630117-B2 | Electrolyte comprising eutectic mixture and electrochromic device using the same | LG CHEM, LTD. (KR) | 2009-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120130114-A1 | METHOD FOR DIRECT FUNCTIONALIZATION OF POLYANILINE AND OTHER MOLECULES HAVING DIIMINOQUINOID RING VIA C-C BOND FORMATION, AND PRODUCT YIELDED THEREWITH | PAICS, PARG, INF2 | HPGD 1610/4885GAA 2630/4885MEN1 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.